Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Glucose replacement agents in frail elderly patients with type ii diabetes in long-term care: clinical and cost-effectiveness, harms, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2015 Authors' conclusions No health technology assessment reports, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, economic evaluations, or evidence-based guidelines were identified regarding glucose replacement agents in frail elderly patients with type II diabetes who reside in long-term care facilities. Indexing Status Subject indexing assigned by CRD MeSH Aged; Diabetes Mellitus; Geriatrics; Glucose; Homes for the Aged; Housing for the Elderly; Hypoglycemia; Long-Term Care; Nursing Homess Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32016000138 Date abstract record published 28/01/2016 |